CD8A and neoplasm: NE acts on β-adrenergic receptors expressed on TAM and tumor-infiltrating lymphocytes, promoting the secretion of factors such as vascular endothelial growth factor (VEGF) and IL-6, while suppressing CD8+ T cell function and inducing M2 macrophage polarization.